NZ322619A - A method of detection of ki-ras mutatios using pcr and phast gel sscp - Google Patents

A method of detection of ki-ras mutatios using pcr and phast gel sscp

Info

Publication number
NZ322619A
NZ322619A NZ322619A NZ32261996A NZ322619A NZ 322619 A NZ322619 A NZ 322619A NZ 322619 A NZ322619 A NZ 322619A NZ 32261996 A NZ32261996 A NZ 32261996A NZ 322619 A NZ322619 A NZ 322619A
Authority
NZ
New Zealand
Prior art keywords
pcr
ras
mutatios
sscp
detection
Prior art date
Application number
NZ322619A
Other languages
English (en)
Inventor
Dagfinn Ogreid
Jan Jacob Koornstra
Arve Ulvik
Original Assignee
Dagfinn Ogreid
Arve Ulvik
Jan Jacob Koornstra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dagfinn Ogreid, Arve Ulvik, Jan Jacob Koornstra filed Critical Dagfinn Ogreid
Publication of NZ322619A publication Critical patent/NZ322619A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Saccharide Compounds (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Holo Graphy (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NZ322619A 1995-11-17 1996-11-15 A method of detection of ki-ras mutatios using pcr and phast gel sscp NZ322619A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO954667A NO954667D0 (no) 1995-11-17 1995-11-17 Fremgangsmåte til deteksjon av Ki-ras mutasjoner
PCT/NO1996/000271 WO1997019191A1 (en) 1995-11-17 1996-11-15 Method for detection of ki-ras mutations and kit to perform it

Publications (1)

Publication Number Publication Date
NZ322619A true NZ322619A (en) 1999-04-29

Family

ID=19898772

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ322619A NZ322619A (en) 1995-11-17 1996-11-15 A method of detection of ki-ras mutatios using pcr and phast gel sscp

Country Status (12)

Country Link
US (1) US6440661B1 (OSRAM)
EP (2) EP0868529B1 (OSRAM)
JP (1) JP2000500346A (OSRAM)
AT (2) ATE251222T1 (OSRAM)
AU (1) AU723980C (OSRAM)
DE (2) DE69635848T2 (OSRAM)
DK (2) DK0868529T3 (OSRAM)
ES (2) ES2208766T3 (OSRAM)
NO (2) NO954667D0 (OSRAM)
NZ (1) NZ322619A (OSRAM)
PT (2) PT868529E (OSRAM)
WO (1) WO1997019191A1 (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715034D0 (en) * 1997-07-18 1997-09-24 Zeneca Ltd Assay
US6964846B1 (en) * 1999-04-09 2005-11-15 Exact Sciences Corporation Methods for detecting nucleic acids indicative of cancer
US6531302B1 (en) * 1999-04-12 2003-03-11 Nanogen/Becton Dickinson Partnership Anchored strand displacement amplification on an electronically addressable microchip
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
AU4714201A (en) 1999-12-07 2001-06-18 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
US7087414B2 (en) 2000-06-06 2006-08-08 Applera Corporation Methods and devices for multiplexing amplification reactions
EP2351853A1 (en) * 2000-06-06 2011-08-03 Life Technologies Corporation Method and devices for multiplexing amplification reactions
US6605451B1 (en) * 2000-06-06 2003-08-12 Xtrana, Inc. Methods and devices for multiplexing amplification reactions
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
US8323897B2 (en) 2002-12-04 2012-12-04 Applied Biosystems, Llc Multiplex amplification of polynucleotides
WO2005113769A1 (en) * 2004-05-14 2005-12-01 Exact Sciences Corporation Method for stabilizing biological samples for nucleic acid analysis
US20070134709A1 (en) * 2005-12-14 2007-06-14 Xiping Xu Usages of MTHFR gene polymorphisms in predicting homocysteine level, disease risk, and treatment effects and related methods and kit
GB2435512A (en) 2006-02-23 2007-08-29 Mologic Ltd A binding assay and assay device
RU2008146868A (ru) 2006-05-18 2010-06-27 Кэрис МПИ, Инк.445 Норт Фифс Стрит, 3-ий Флор, Феникс, Аризона 85004, США (US) Система и способ определения персонализированого медицинского вмешательства при болезненном состоянии
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
GB2463401B (en) 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
CA2786005A1 (en) * 2009-12-31 2011-07-07 Van Andel Research Institute Methods for diagnosing the malignant potential of pancreatic cystic lesions
CN103237901B (zh) 2010-03-01 2016-08-03 卡里斯生命科学瑞士控股有限责任公司 用于治疗诊断的生物标志物
EP2556172A4 (en) 2010-04-06 2013-10-30 Caris Life Sciences Luxembourg Holdings CIRCULATING BIOMARKERS FOR DISEASES
US9309556B2 (en) 2010-09-24 2016-04-12 The Board Of Trustees Of The Leland Stanford Junior University Direct capture, amplification and sequencing of target DNA using immobilized primers
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
CN102796811B (zh) * 2011-05-26 2013-12-18 上海赛安生物医药科技有限公司 检测kras突变的试剂及方法
EP2721140B1 (en) 2011-06-19 2016-11-23 Abogen, Inc. Devices, solutions and methods for sample collection
JP5947392B2 (ja) * 2011-11-17 2016-07-06 ザ ジョンズ ホプキンス ユニバーシティー 膵嚢胞の鑑別
KR20150090240A (ko) * 2012-11-30 2015-08-05 어플라이드 프로테오믹스, 인크. 결장 종양의 존재 또는 위험의 평가 방법
AU2015226811B2 (en) 2014-03-07 2021-07-15 Dna Genotek Inc. Composition and method for stabilizing nucleic acids in biological samples
GB2545361B (en) 2015-04-10 2018-01-24 Applied Proteomics Inc Methods of assessing colorectal cancer status
US10753936B2 (en) 2016-07-22 2020-08-25 Van Andel Research Institute Method of detecting the level of a glycan
WO2019246286A1 (en) 2018-06-19 2019-12-26 Neon Therapeutics, Inc. Neoantigens and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871838A (en) * 1985-07-23 1989-10-03 The Board Of Rijks Universiteit Leiden Probes and methods for detecting activated ras oncogenes
US5137806A (en) * 1989-12-11 1992-08-11 Board Of Regents, The University Of Texas System Methods and compositions for the detection of sequences in selected DNA molecules
IL97222A (en) * 1990-02-16 1995-08-31 Orion Yhtymae Oy Method and reagent for determining specific nucleotide variations
WO1993020235A1 (en) 1992-04-01 1993-10-14 The Johns Hopkins University School Of Medicine Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor
EP0655090B1 (en) * 1992-04-27 2000-12-27 The Trustees Of Dartmouth College Detection of gene sequences in biological fluids
JPH06167492A (ja) * 1992-11-30 1994-06-14 Otsuka Pharmaceut Co Ltd 変異癌遺伝子の検出測定方法
DE19512369A1 (de) * 1995-04-01 1996-10-02 Boehringer Mannheim Gmbh Vorrichtung zur Isolierung von Nukleinsäuren

Also Published As

Publication number Publication date
AU723980B2 (en) 2000-09-07
DK1394272T3 (da) 2006-07-03
NO324963B1 (no) 2008-01-14
ATE251222T1 (de) 2003-10-15
NO982246D0 (no) 1998-05-15
DE69630234T2 (de) 2004-08-19
EP1394272B1 (en) 2006-03-01
WO1997019191A1 (en) 1997-05-29
NO954667D0 (no) 1995-11-17
EP1394272A1 (en) 2004-03-03
ES2208766T3 (es) 2004-06-16
DK0868529T3 (da) 2004-02-02
PT1394272E (pt) 2006-07-31
AU723980C (en) 2002-10-24
DE69635848D1 (de) 2006-04-27
ES2262930T3 (es) 2006-12-01
US6440661B1 (en) 2002-08-27
EP0868529A1 (en) 1998-10-07
AU7656996A (en) 1997-06-11
ATE318934T1 (de) 2006-03-15
NO982246L (no) 1998-07-07
PT868529E (pt) 2004-02-27
DE69630234D1 (de) 2003-11-06
DE69635848T2 (de) 2006-11-30
EP0868529B1 (en) 2003-10-01
JP2000500346A (ja) 2000-01-18

Similar Documents

Publication Publication Date Title
NZ322619A (en) A method of detection of ki-ras mutatios using pcr and phast gel sscp
AU605743B2 (en) Method for detecting, identifying and quantitating non-viral organisms
EP0832691A3 (en) Protective shield for a blood glucose strip
EP0357611A4 (en) A method of detection of carcinogenic human papillomavirus
NZ284412A (en) Apolipoprotein E polymorphism and treatment of Alzheimer's Disease
AU580270B2 (en) Composition and method for rapid detection of microorganisms in clinical samples
CA2071636A1 (en) Genetic assay for cytochrome p450 iid bufuralol-1'- hydroxylase
NZ217441A (en) Detecting microbial pathogens in body fluid sample
AU612571B2 (en) Oligonucleotidic probes and methods for the detection of bacterial and other living beings by hybridization of nucleic acids
GR3005272T3 (OSRAM)
EP0419502A4 (en) Method of detecting bacteria in urine
AU1272000A (en) Method for the quantitative detection of nucleic acids
AU3776095A (en) Improved methodology for colorimetrically determining the concentration of white blood cells in a biological fluid
EP0404210A3 (en) A method and probe for the detection of cells associated with human oral medical disorders or with healthy human gingiva
EP0567230A3 (en) Method and apparatus for detecting microorganisms in culture flasks.
GB2235769B (en) Detection of inherited disease alleles in DNA samples using yeast artificial chromosomes
GB2291714B (en) Biological species detection method and biosensor therefor
FR2590591B1 (fr) Adnc codant pour la manganese-superoxyde-dismutase humaine, son expression dans des bacteries et procede pour recueillir de la manganese-superoxyde-dismutase humaine douee d'activite enzymatique.
AU2283792A (en) Direct detection of hepatitis c virus rna
EP0807689A4 (en) METHOD FOR DETECTING CELLS
EP0497820A4 (en) Ribozyme inhibitors
EP0668613A4 (en) METHOD FOR DETERMINING THE OXYGEN CONCENTRATION IN SILICON CRYSTALS.
AU5709698A (en) Methods for treating insulin resistance and identifying patients at risk for thedisease
Pasargiklian et al. Laboratory evaluation of a radiometric system.
EP1338896A3 (en) ICAM-4 and diagnostic uses thereof

Legal Events

Date Code Title Description
S38A Application for proceedings under section 38 (amendment of specification with leave of commissioner)

Free format text: BY WAY OF CORRECTION

S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: NORDIAG AS, NO

Free format text: OLD OWNER(S): JAN JACOB KOORNSTRA; ARVE ULVIK; DAGFINN OGREID

RENW Renewal (renewal fees accepted)